Free Trial

Brainstorm Cell Therapeutics (BCLI) Institutional Ownership

Brainstorm Cell Therapeutics logo
$0.71 +0.00 (+0.27%)
As of 03:55 PM Eastern

Institutional Ownership Changes (13F Filings) for Brainstorm Cell Therapeutics (NASDAQ:BCLI)

Current
Institutional Ownership
Percentage
14.33%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$899.30K
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$2.67M
Get BCLI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Brainstorm Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BCLI Institutional Buying and Selling by Quarter

Brainstorm Cell Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/24/2025 Gunderson Capital Management Inc.25,950$29K0.0%N/A0.264%
5/15/2025Armistice Capital LLC690,666$870K0.0%N/A10.590%
2/14/2025Two Sigma Securities LLC11,300$26K0.0%-42.9%0.198%
2/12/2025Geode Capital Management LLC52,501$119K0.0%-92.3%0.921%
2/10/2025Liberty Wealth Management LLC22,666$51K0.0%-93.3%0.397%
1/8/2025Weaver Consulting Group15,623$35K0.0%-93.3%0.274%
8/15/2024Armistice Capital LLC7,917,653$2.68M0.0%N/A11.298%
4/15/2024Kingswood Wealth Advisors LLC81,050$46K0.0%N/A0.119%
8/14/2023Mirador Capital Partners LP25,084$52K0.0%N/A0.064%
8/9/2023Kingswood Wealth Advisors LLC16,600$34K0.0%N/A0.042%
7/31/2023Socha Financial Group LLC12,380$26K0.0%N/A0.031%
7/26/2023Janney Montgomery Scott LLC20,000$41K0.0%N/A0.051%
7/12/2023Professional Financial Advisors LLC17,279$36K0.0%N/A0.044%
5/15/2023AIGH Capital Management LLC1,459,095$4.82M1.8%N/A3.978%
5/10/2023Nelson Van Denburg & Campbell Wealth Management Group LLC12,686$42K0.0%N/A0.035%
5/3/2023Liberty Wealth Management LLC150,400$496K0.1%N/A0.410%
4/26/2023TRU Independence Asset Management 2 LLC44,000$145K0.1%N/A0.120%
4/14/2023Raymond James Financial Services Advisors Inc.11,248$37K0.0%N/A0.031%
4/14/2023Raymond James & Associates164,703$544K0.0%-22.6%0.449%
11/15/2022Liberty Wealth Management LLC40,000$176K0.0%+33.3%0.110%
11/14/2022Boothbay Fund Management LLC19,098$84K0.0%-31.5%0.052%
11/8/2022IFP Advisors Inc28,850$151K0.0%+45.3%0.079%
11/3/2022Creative Planning30,681$136K0.0%N/A0.084%
10/31/2022TRU Independence Asset Management 2 LLC44,000$194K0.2%N/A0.121%
10/25/2022Janney Montgomery Scott LLC20,000$88K0.0%N/A0.055%
10/25/2022Raymond James & Associates244,803$1.08M0.0%+30.6%0.671%
10/20/2022Jmac Enterprises LLC40,430$179K0.1%-11.0%0.111%
10/6/2022Abner Herrman & Brock LLC280,000$1.24M0.2%+5.7%0.767%
8/12/2022Ikarian Capital LLC253,432$698K0.1%-16.7%0.695%
7/20/2022Weaver Consulting Group104,653$289K0.2%-19.5%0.287%
7/11/2022S.C. Financial Services Inc.25,471$70K0.1%+66.6%0.070%
5/6/2022Weaver Consulting Group130,000$437K0.2%-16.4%0.356%
4/7/2022Abner Herrman & Brock LLC265,000$890K0.1%+13.7%0.726%
2/9/2022Geneos Wealth Management Inc.10,100$40K0.0%N/A0.028%
2/8/2022Steward Partners Investment Advisory LLC9,700$39K0.0%-42.9%0.027%
2/8/2022Raymond James & Associates189,503$758K0.0%-11.4%0.522%
2/2/2022Aptus Capital Advisors LLC12,500$50K0.0%-21.9%0.034%
2/1/2022Weaver Consulting Group155,500$622K0.3%+201.9%0.429%
1/26/2022S.C. Financial Services Inc.15,285$52K0.1%N/A0.042%
1/13/2022Abner Herrman & Brock LLC233,000$932K0.1%+13.7%0.642%
11/15/2021GSA Capital Partners LLP172,056$568K0.1%+185.6%0.474%
11/9/2021BlackRock Inc.468,967$1.55M0.0%-1.1%1.293%
10/6/2021Abner Herrman & Brock LLC205,000$676K0.1%-15.1%0.564%
8/17/2021Millennium Management LLC371,460$1.41M0.0%N/A1.023%
8/17/2021Price T Rowe Associates Inc. MD93,000$353K0.0%-23.9%0.256%
8/16/2021LMR Partners LLP11,735$45K0.0%N/A0.032%
8/16/2021Charles Schwab Investment Management Inc.11,287$43K0.0%-85.6%0.031%
8/16/2021State Street Corp86,703$329K0.0%-83.2%0.239%
8/16/2021Tibra Equities Europe Ltd87,000$331K0.1%N/A0.240%
8/16/2021Goldman Sachs Group Inc.57,679$220K0.0%+144.4%0.159%
8/13/2021Renaissance Technologies LLC47,600$181K0.0%N/A0.131%
8/13/2021Steward Partners Investment Advisory LLC19,000$72K0.0%-38.3%0.052%
8/13/2021Northern Trust Corp49,761$189K0.0%-83.4%0.137%
8/13/2021Geode Capital Management LLC265,138$1.01M0.0%-44.6%0.730%
8/13/2021Vanguard Group Inc.1,412,826$5.37M0.0%+6.2%3.890%
8/12/2021JPMorgan Chase & Co.698,294$2.65M0.0%-13.3%1.923%
8/12/2021Ergoteles LLC124,329$472K0.0%N/A0.342%
8/11/2021Bank of New York Mellon Corp15,899$61K0.0%-82.1%0.044%
8/11/2021BlackRock Inc.474,347$1.80M0.0%-75.7%1.306%
8/2/2021Advisor Group Holdings Inc.10,920$42K0.0%-54.5%0.030%
(Data available from 1/1/2016 forward)

BCLI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BCLI shares?

During the previous two years, the following institutional investors and hedge funds held shares of Brainstorm Cell Therapeutics shares: Armistice Capital LLC ($870K), Geode Capital Management LLC ($119K), Liberty Wealth Management LLC ($51K), Kingswood Wealth Advisors LLC ($46K), Weaver Consulting Group ($35K), and Gunderson Capital Management Inc. ($29K), and Two Sigma Securities LLC ($26K).Learn more on Brainstorm Cell Therapeutics' institutional investors.

What percentage of Brainstorm Cell Therapeutics' stock is owned by institutional investors?

14.33% of Brainstorm Cell Therapeutics' stock is owned by institutional investors. Learn more on BCLI's institutional investor holdings.

Which institutional investors have been buying Brainstorm Cell Therapeutics' stock?

The following institutional investors have purchased Brainstorm Cell Therapeutics' stock in the last 24 months: Armistice Capital LLC ($8.61M), Kingswood Wealth Advisors LLC ($81.05K), and Gunderson Capital Management Inc. ($25.95K).

How much institutional buying is happening at Brainstorm Cell Therapeutics?

Institutional investors have bought a total of 716,616 shares in the last 24 months. This purchase volume represents approximately $899.30K in transactions.

Which of Brainstorm Cell Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Brainstorm Cell Therapeutics stock in the last 24 months: Geode Capital Management LLC ($630.32K), Liberty Wealth Management LLC ($317.48K), Weaver Consulting Group ($218.73K), and Two Sigma Securities LLC ($8.50K).

How much institutional selling is happening at Brainstorm Cell Therapeutics?

Institutional investors have sold a total of 1,175,028 shares in the last 24 months. This volume of shares sold represents approximately $2.67M in transactions.



This page (NASDAQ:BCLI) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners